RDY 453 (Venlafaxine Extended Release 37.5 mg)

Pill imprint RDY 453 has been identified as Venlafaxine hydrochloride extended release 37.5 mg.

Venlafaxine is used in the treatment of major depressive disorder; hot flashes; anxiety; anxiety and stress; fibromyalgia (and more), and belongs to the drug class serotonin-norepinephrine reuptake inhibitors. Risk cannot be ruled out during pregnancy. Venlafaxine 37.5 mg is not a controlled substance under the Controlled Substance Act (CSA).

Venlafaxine hydrochloride extended release

Imprint:

RDY 453

Strength:

37.5 mg

Color:

Gray & Pink

Shape:

Capsule-shape

Availability:

Prescription only

Drug Class:

Serotonin-norepinephrine reuptake inhibitors

Pregnancy Category:

C - Risk cannot be ruled out

CSA Schedule:

Not a controlled drug

Manufacturer:

Dr.Reddy's Laboratories Ltd.

National Drug Code (NDC):

55111-0453

Inactive Ingredients:

dimethylaminoethyl methacrylate - butyl methacrylate - methyl methacrylate copolymer
ethylcelluloses
gelatin
medium-chain triglycerides
microcrystalline cellulose
povidone
ferric oxide red
sodium stearyl fumarate
magnesium silicate
titanium dioxide
ferrosoferric oxide
ferric oxide yellow
potassium hydroxide
propylene glycol
shellac
ammonia

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.